Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - BIOCLINICA INC | w80385e10vq.htm |
| EX-31.2 - EX-31.2 - BIOCLINICA INC | w80385exv31w2.htm |
| EX-32.2 - EX-32.2 - BIOCLINICA INC | w80385exv32w2.htm |
| EX-31.1 - EX-31.1 - BIOCLINICA INC | w80385exv31w1.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of BioClinica, Inc. (the “Company”) for
the quarter ended September 30, 2010 as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), the undersigned, Mark L. Weinstein, President and Chief Executive
Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of BioClinica, Inc.
| Dated: November 8, 2010 | /s/ Mark L. Weinstein* | |||
| Mark L. Weinstein, President and | ||||
| Chief Executive Officer (Principal Executive Officer) |
||||
| * | A signed original of this written statement required by Section 906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or its staff upon request. |